IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ligand Pharmaceuticals Inc

CUSIP: 53220K207 | 3 institutional holders

Quarters

Q1 2014Q4 2013Q3 2013Q2 2013
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2014

Benchmark Capital Advisors20,800
0.0% of portfolio›$1.4K
StyleTurnoverLocationFiled
Benchmark Capital Advisors
20,800$1.4K0.0%N/AN/ANew York, NY2014-04-16